array-cgh Search Results


90
Treff AG comparative genomic hybridisation acgh
Comparative Genomic Hybridisation Acgh, supplied by Treff AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/comparative genomic hybridisation acgh/product/Treff AG
Average 90 stars, based on 1 article reviews
comparative genomic hybridisation acgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare array cgh analysis
Array Cgh Analysis, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array cgh analysis/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
array cgh analysis - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Helmholtz Zentrum fur Infektionsforschung GmbH array cgh
Array Cgh, supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array cgh/product/Helmholtz Zentrum fur Infektionsforschung GmbH
Average 90 stars, based on 1 article reviews
array cgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BlueGnome Limited array cgh
Array Cgh, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array cgh/product/BlueGnome Limited
Average 90 stars, based on 1 article reviews
array cgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BlueGnome Limited 24-h array-cgh protocol
24 H Array Cgh Protocol, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/24-h array-cgh protocol/product/BlueGnome Limited
Average 90 stars, based on 1 article reviews
24-h array-cgh protocol - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
PreventionGenetics llc gene-centric array cgh
Gene Centric Array Cgh, supplied by PreventionGenetics llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene-centric array cgh/product/PreventionGenetics llc
Average 90 stars, based on 1 article reviews
gene-centric array cgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CombiMatrix array cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh, supplied by CombiMatrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array cgh/product/CombiMatrix
Average 90 stars, based on 1 article reviews
array cgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Genotypic Technology Pvt Ltd array cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh, supplied by Genotypic Technology Pvt Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array cgh/product/Genotypic Technology Pvt Ltd
Average 90 stars, based on 1 article reviews
array cgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Signature Genomic Laboratories LLC array cgh signaturechip
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh Signaturechip, supplied by Signature Genomic Laboratories LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array cgh signaturechip/product/Signature Genomic Laboratories LLC
Average 90 stars, based on 1 article reviews
array cgh signaturechip - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Genentech inc snp/chip array-cgh data
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Snp/Chip Array Cgh Data, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snp/chip array-cgh data/product/Genentech inc
Average 90 stars, based on 1 article reviews
snp/chip array-cgh data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
NimbleGen Systems GmbH array-cgh platform
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh Platform, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array-cgh platform/product/NimbleGen Systems GmbH
Average 90 stars, based on 1 article reviews
array-cgh platform - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MOgene Inc array-cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh, supplied by MOgene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/array-cgh/product/MOgene Inc
Average 90 stars, based on 1 article reviews
array-cgh - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma

Journal: Orphanet Journal of Rare Diseases

Article Title: Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

doi: 10.1186/1750-1172-8-112

Figure Lengend Snippet: Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma

Article Snippet: Whole-genome array-based comparative genomic hybridization (array CGH) was performed by using the CLIA-certified DNAarrayTM (CombiMatrix Diagnostics, Irvine, CA).

Techniques: Sequencing, Hybridization, Immunohistochemistry, Staining

Imaging studies, histopathology and FISH studies: UA and B: CT of the chest showing metastatic masses in the lung. C Hematoxylin and Eosin stained section of the tumor from the right mastectomy shows a malignant sarcoma/malignant phyllodes tumor that has high stromal cellularity and a mitotic index of 11 per 10 high power fields. D HER - 2 / neu by Fluorescence in Situ Hybridization (FISH) HER-2 gene amplification was assessed utilizing the PathVysion assay (Vysis Corp., Downers Grove, Illinois). The identification probes for the HER-2 (SpectrumOrange) and alpha satellite DNA sequence at the centromeric region of chromosome 17 (SpectrumGreen) were hybridized according to the manufacturer’s guidelines. At least twenty non-overlapping nuclei containing at least one orange and one green signal were enumerated. The ratio of orange signals (HER-2 gene) to green signals (chromosome 17) was calculated. A ratio greater than or equal to 2.0 is considered as amplified based on the FDA approval in this kit. The CAP HER-2 consensus conference 2002 suggested that a ratio of 1.8-2.2 be considered as borderline.

Journal: Orphanet Journal of Rare Diseases

Article Title: Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

doi: 10.1186/1750-1172-8-112

Figure Lengend Snippet: Imaging studies, histopathology and FISH studies: UA and B: CT of the chest showing metastatic masses in the lung. C Hematoxylin and Eosin stained section of the tumor from the right mastectomy shows a malignant sarcoma/malignant phyllodes tumor that has high stromal cellularity and a mitotic index of 11 per 10 high power fields. D HER - 2 / neu by Fluorescence in Situ Hybridization (FISH) HER-2 gene amplification was assessed utilizing the PathVysion assay (Vysis Corp., Downers Grove, Illinois). The identification probes for the HER-2 (SpectrumOrange) and alpha satellite DNA sequence at the centromeric region of chromosome 17 (SpectrumGreen) were hybridized according to the manufacturer’s guidelines. At least twenty non-overlapping nuclei containing at least one orange and one green signal were enumerated. The ratio of orange signals (HER-2 gene) to green signals (chromosome 17) was calculated. A ratio greater than or equal to 2.0 is considered as amplified based on the FDA approval in this kit. The CAP HER-2 consensus conference 2002 suggested that a ratio of 1.8-2.2 be considered as borderline.

Article Snippet: Whole-genome array-based comparative genomic hybridization (array CGH) was performed by using the CLIA-certified DNAarrayTM (CombiMatrix Diagnostics, Irvine, CA).

Techniques: Imaging, Histopathology, Staining, Fluorescence, In Situ Hybridization, Amplification, Sequencing